Concepedia

Publication | Open Access

A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study

DOIFull Paper Access

26

Citations

24

References

2022

Year

Magali Rebucci-Peixoto, Angélique Vienot, Olivier Adotévi, Marion Jacquin, François Ghiringhelli, Christelle de la Fouchardière, Benoît You, Tristan Maurina, Elsa Kalbacher, Fernando Bazán,
Frontiers in Oncology

Abstract

https://www.clinicaltrials.gov/, identifier NCT03946358.

References

YearCitations

Page 1